Free Newsletter
Brain chemical regulates weight, appetite
By studying the victims of a rare genetic disease, NIH researchers have highlighted the role that brain-derived neurotrophic factor--a chemical made in the brain--has on promoting obesity. People with WAGR syndrome lack a gene for BDNF and also are known for huge appetites and obesity. That link could point researchers to a new approach to controlling obesity.
"This is a promising new lead in the search for biological pathways that contribute to obesity," said Duane Alexander, M.D., director of the NIH's Eunice Kennedy Shriver National Institute of Child Health and Human Development. "This finding may eventually lead to the development of new drugs to regulate appetite in people who have not had success with other treatments."
- read the release for more
Related Articles:
'Brown fat' may be a key to curing obesity
Obesity drugs pose weighty problems for researchers
LRPR1: A new target for obesity, diabetes
Molecular research points to new obesity therapy
Comments
Post new comment
Paid Research Reports
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
- Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
- The CRO Market Outlook: Emerging markets, leading players and future trends
- Pharmaceutical Sales Force Effectiveness Strategies
- Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact




